Botulism differential diagnosis
|
Botulism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Botulism differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Botulism differential diagnosis |
|
Risk calculators and risk factors for Botulism differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Keanu Ngo[2]
Overview
Botulism produces an acute, afebrile, symmetric, descending flaccid paralysis that begins with cranial-nerve (oculobulbar) dysfunction in an alert patient with intact sensation. It must be differentiated from other disorders of the neuromuscular junction, peripheral nerve/root, motor neuron, muscle, and brainstem, as well as from neurotoxin exposures that impair cholinergic transmission. In a CDC series of 332 U.S. cases (>12 months of age), the illnesses most often on the treating physician's differential were Guillain-Barré syndrome (GBS) and myasthenia gravis (MG); classic features were common, but "atypical" findings (e.g., paresthesias in 17%, elevated CSF protein in 13%, unilateral or ascending findings in a minority) were also reported, so no single feature excludes the diagnosis.[1][2] Because treatment is time-critical and clinical, differentiation should proceed in parallel with, not before, antitoxin decision-making.
Discriminating features of botulism
The following features, taken together, favor botulism over its mimics:[3][4]
- Descending course beginning with the eyes/bulbar muscles (diplopia, ptosis, dysarthria, dysphagia), in contrast to the classically ascending pattern of GBS and tick paralysis.
- Symmetric weakness with preserved sensorium and no true sensory loss (paresthesias may rarely occur).
- Afebrile presentation (fever suggests a superimposed infection or an alternative diagnosis; it may occur in wound botulism).
- Autonomic/cholinergic signs: fixed or sluggish dilated pupils (mydriasis), dry mouth, ileus/constipation, urinary retention.
- Normal CSF (protein usually normal), normal neuroimaging, and a characteristic electrodiagnostic profile (below).
Differential diagnosis in adults and older children
| Disorder | Weakness pattern | Sensory loss | Reflexes | Pupils/autonomic | Fever | Key discriminator / confirmatory test |
|---|---|---|---|---|---|---|
| Botulism | Descending, symmetric | Absent | Reduced/absent | Mydriasis, dry mouth, ileus | No | Toxin in serum/stool/food; EDx: low CMAP, incremental response to high-frequency (30–50 Hz) RNS or post-exercise facilitation[5] |
| Guillain-Barré syndrome (AIDP) | Ascending, symmetric | Present (distal paresthesias) | Absent early | Labile dysautonomia | No | CSF albuminocytologic dissociation (may be delayed 1–2 wk); demyelinating NCS[6][7] |
| Miller Fisher variant of GBS | Ophthalmoplegia, ataxia, areflexia (can mimic bulbar botulism) | Variable | Absent | Usually spared | No | Anti-GQ1b antibody; ascending peripheral involvement[8] |
| Myasthenia gravis | Fatigable ocular/bulbar/limb, fluctuating | Absent | Normal | Pupils spared | No | AChR/MuSK antibodies; decrement on low-frequency RNS; edrophonium response[9] |
| Lambert-Eaton myasthenic syndrome | Proximal legs>arms; weakness improves briefly with exertion | Absent | Reduced (facilitate after exercise) | Dry mouth, autonomic | No | Anti-P/Q-type VGCC antibody; marked (>60–100%) post-exercise facilitation; SCLC screen[10] |
| Tick paralysis | Ascending, symmetric | Absent | Reduced/absent | Mydriasis possible (Ixodes) | No | Finding and removing the attached tick (scalp, groin); normal CSF[11][12] |
| Organophosphate/carbamate poisoning | Generalized, fasciculations, weakness | Absent | Variable | Miosis, muscarinic excess (SLUDGE), bronchorrhea | +/– | Cholinergic toxidrome; reduced RBC/plasma cholinesterase; exposure history |
| Tetrodotoxin / paralytic shellfish poisoning | Rapid descending paralysis, perioral paresthesias | Paresthesias | Variable | Autonomic instability | No | Ingestion history (pufferfish/shellfish); rapid onset (minutes–hours)[13] |
| Brainstem stroke / Bickerstaff encephalitis | Often asymmetric; crossed signs | +/– | Variable | Gaze palsy; altered consciousness (Bickerstaff) | No | MRI (ischemia/hemorrhage/brainstem lesion); altered sensorium |
| Poliomyelitis / acute flaccid myelitis | Asymmetric, proximal | Absent (motor) | Reduced | +/– | Yes (febrile prodrome) | Preceding febrile illness; CSF pleocytosis; MRI cord/anterior horn; viral PCR |
Detailed test performance and interpretation are covered in Laboratory findings and Other diagnostic studies.
Differential diagnosis in infants
In infant botulism (≈95% of confirmed cases occur before 6 months of age), the most common admitting diagnosis is sepsis; as hypotonia progresses, the differential broadens.[14] Analyses of infants treated with BIG-IV but not confirmed to have botulism ("clinical mimics") identify five recurring categories: spinal muscular atrophy type I, metabolic disorders, other infectious diseases, miscellaneous conditions, and probable (untested) infant botulism.[15]
- Sepsis/meningoencephalitis — febrile, ill-appearing; positive cultures/CSF.[16]
- Spinal muscular atrophy type I — longer history of weakness; spares extraocular muscles and sphincters (both characteristically involved in botulism); tongue fasciculations; SMN1 genetic testing.[17]
- Transient neonatal / congenital myasthenic syndromes — onset in first days of life; maternal MG history (transient form); genetic testing.[18]
- Metabolic/inborn errors, hypothyroidism — targeted metabolic and endocrine studies.[19]
- GBS (including Miller Fisher) — rare in infancy, occurs in older children; elevated CSF protein and NCS/EMG distinguish it.[20]
The edrophonium (Tensilon) test is generally not indicated in infants, because congenital MG is excluded by history and de novo autoimmune MG does not occur at this age.[21]
Electrodiagnostic differentiation
Electrodiagnostic testing is the single most useful ancillary study for separating botulism from GBS, MG, and LEMS:[22][23]
- Botulism: low resting CMAP amplitudes with normal motor conduction velocities and normal sensory studies; post-exercise facilitation and an incremental response to high-frequency (30–50 Hz) RNS — the most distinctive finding. Small, short-duration MUAPs on needle EMG. Facilitation in botulism is typically less pronounced than in LEMS but more persistent (minutes).
- MG: decrement on low-frequency (2–3 Hz) RNS; normal CMAP at rest; abnormal SFEMG jitter.[24]
- LEMS: low resting CMAP with marked (>60–100%) post-exercise facilitation and decrement at low-frequency RNS.[25]
- GBS: demyelinating features (prolonged distal latencies, conduction block, slowed velocities, prolonged/absent F-waves); electrodiagnostic abnormalities may be delayed in the first week.[26]
Caveats: In botulism, incremental responses may be absent early or in severe cases, and both HFRNS and post-exercise facilitation lose sensitivity in the post-acute phase; a normal study does not exclude botulism.[27][28]
Clinically actionable points
- Use the descending vs. ascending distinction and pupillary/autonomic signs as first-line bedside discriminators; confirm with EDx and toxin testing.[29]
- Do not delay antitoxin while excluding mimics; empiric treatment on clinical suspicion is standard.[30]
- Search thoroughly for an attached tick (scalp, groin) in any acute ascending flaccid paralysis—removal is curative and averts unnecessary testing.[31]
- Clustering of cases of symmetric descending paralysis strongly suggests botulism (or shellfish/toxin exposure) and mandates immediate public-health notification.[32]
References
- ↑ Rao AK; Lin NH; Jackson KA; Mody RK; Griffin PM (2017). "Clinical Characteristics and Ancillary Test Results Among Patients With Botulism—United States, 2002-2015". Clinical Infectious Diseases. PMID 29293936.
- ↑ Lonati D; Schicchi A; Crevani M; et al. (2020). "Foodborne Botulism: Clinical Diagnosis and Medical Treatment". Toxins. PMID 32784744 Check
|pmid=value (help). - ↑ Rao AK; Lin NH; Jackson KA; Mody RK; Griffin PM (2017). "Clinical Characteristics and Ancillary Test Results Among Patients With Botulism—United States, 2002-2015". Clinical Infectious Diseases. PMID 29293936.
- ↑ Gayed SMA; Motley MP; Carlson JM; Lupu KS; Mavrogiorgos N (2026). "The Eyes Have It". The New England Journal of Medicine. 394 (10): 1011–1017. doi:10.1056/NEJMcps2508044.
- ↑ Morena JM (2026). "Electrodiagnostic Approach to Defects of Neuromuscular Transmission". Muscle & Nerve.
- ↑ Shahrizaila N; Lehmann HC; Kuwabara S (2021). "Guillain-Barré Syndrome". Lancet.
- ↑ Yuki N; Hartung HP (2012). "Guillain–Barré Syndrome". The New England Journal of Medicine.
- ↑ Carrillo-Marquez MA (2016). "Botulism". Pediatrics in Review. 37 (5): 183–192. doi:10.1542/pir.2015-0018.
- ↑ Punga AR; Maddison P; Heckmann JM; Guptill JT; Evoli A (2022). "Epidemiology, Diagnostics, and Biomarkers of Autoimmune Neuromuscular Junction Disorders". The Lancet Neurology.
- ↑ Gable KL; Massey JM (2015). "Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism". Seminars in Neurology. PMID 26502758.
- ↑ García-Moncó JC; Benach JL (2025). "Tick-induced neurological disorders". Journal of Neurology.
- ↑ Edlow JA (2024). "Tick Paralysis—A Rare but Important Tick-Borne Disease". JAMA Internal Medicine.
- ↑ Gayed SMA; Motley MP; Carlson JM; Lupu KS; Mavrogiorgos N (2026). "The Eyes Have It". The New England Journal of Medicine. 394 (10): 1011–1017. doi:10.1056/NEJMcps2508044.
- ↑ Carrillo-Marquez MA (2016). "Botulism". Pediatrics in Review. 37 (5): 183–192. doi:10.1542/pir.2015-0018.
- ↑ Khouri JM; Payne JR; Arnon SS (2018). "More Clinical Mimics of Infant Botulism". The Journal of Pediatrics. PMID 29229451.
- ↑ Carrillo-Marquez MA (2016). "Botulism". Pediatrics in Review. 37 (5): 183–192. doi:10.1542/pir.2015-0018.
- ↑ Carrillo-Marquez MA (2016). "Botulism". Pediatrics in Review. 37 (5): 183–192. doi:10.1542/pir.2015-0018.
- ↑ Corrado A; Yoshiba G; Buranosky M; et al. (2022). "A 43-Day-Old Male With Respiratory Distress and Acute-Onset Hypotonia". Pediatrics.
- ↑ Khouri JM; Payne JR; Arnon SS (2018). "More Clinical Mimics of Infant Botulism". The Journal of Pediatrics. PMID 29229451.
- ↑ Berkwitt A; El Saleeby CM; Murphy SA (2024). "Case 3-2024: An 8-Week-Old Male Infant with Inconsolable Crying and Weakness". The New England Journal of Medicine.
- ↑ Carrillo-Marquez MA (2016). "Botulism". Pediatrics in Review. 37 (5): 183–192. doi:10.1542/pir.2015-0018.
- ↑ Morena JM (2026). "Electrodiagnostic Approach to Defects of Neuromuscular Transmission". Muscle & Nerve.
- ↑ Boccagni C; Prestandrea C; D'Agostino T; et al. (2021). "Neurophysiological patterns of acute and post-acute foodborne botulism". Muscle & Nerve.
- ↑ Punga AR; Maddison P; Heckmann JM; Guptill JT; Evoli A (2022). "Epidemiology, Diagnostics, and Biomarkers of Autoimmune Neuromuscular Junction Disorders". The Lancet Neurology.
- ↑ Gable KL; Massey JM (2015). "Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism". Seminars in Neurology. PMID 26502758.
- ↑ Willison HJ; Jacobs BC; van Doorn PA (2016). "Guillain-Barré Syndrome". Lancet.
- ↑ Boccagni C; Prestandrea C; D'Agostino T; et al. (2021). "Neurophysiological patterns of acute and post-acute foodborne botulism". Muscle & Nerve.
- ↑ Liu SC; Poon JT; Candee MS (2021). "Clinical Reasoning: A Teenager With Shortness of Breath and Difficulty Walking". Neurology.
- ↑ Shahrizaila N; Lehmann HC; Kuwabara S (2021). "Guillain-Barré Syndrome". Lancet.
- ↑ Gayed SMA; Motley MP; Carlson JM; Lupu KS; Mavrogiorgos N (2026). "The Eyes Have It". The New England Journal of Medicine. 394 (10): 1011–1017. doi:10.1056/NEJMcps2508044.
- ↑ Edlow JA (2024). "Tick Paralysis—A Rare but Important Tick-Borne Disease". JAMA Internal Medicine.
- ↑ Gayed SMA; Motley MP; Carlson JM; Lupu KS; Mavrogiorgos N (2026). "The Eyes Have It". The New England Journal of Medicine. 394 (10): 1011–1017. doi:10.1056/NEJMcps2508044.